The precise association between lncRNA H19 and ferroptosis in the context of atherosclerosis remains uncertain.
OBJECTIVE:
This study is to clarify the underlying process and propose novel approaches for the advancement of therapeutic interventions targeting atherosclerosis.
METHODS:
Assessment of ferroptosis, which entails the evaluation of cell viability using CCK-8 and the quantification of intracellular MDA, GSH, and ferrous ions. Simultaneously, the protein expression levels of assessed by western blot analysis, while the expression level of lncRNA H19 was also determined. Furthermore, HAECs that were cultured with ox-LDL were subjected to Fer-1 interference. HAECs were exposed to ox-LDL and then transfected with H19 shRNA and H19 overexpression vector pcDNA3.1. The level of ferroptosis in the cells was then measured. Then, HAECs were subjected to incubation with ox-LDL, followed by transfection with H19 shRNA and treated with Erastin to assess the levels of ferroptosis, cell viability, and inflammatory factor production. and the ability for blood vessel development.
RESULTS:
The survival rate of HAECs in the ox-LDL group was much lower. Ox-LDL resulted in an upregulation of ACSL4 expression in HAECs, while the expression of SLC7A11 and GPX4 decreased.
CONCLUSIONS:
lncRNA H19 enhances ferroptosis and exacerbates arterial endothelial cell damage induced by LDL.
MagalhaesJE, Sampaio Rocha-FilhoPA. Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations. Headache. 2018;58(8):1277–86.
2.
Global Cardiovascular Risk Consortium, MagnussenC, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389(14):1273–85.
3.
ZhangR, HaoY, ZhangJ. The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway. Cell Mol Biol Lett. 2022;27(1):15.
4.
MilutinovicA, SuputD, Zorc-PleskovicR. Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries: An updated review. Bosn J Basic Med Sci. 2020;20(1):21–30.
5.
HoweKL, FishJE. Transforming endothelial cells in atherosclerosis. Nat Metab. 2019;1(9):856–7.
6.
MartinetW, et al. Macrophage Death as a Pharmacological Target in Atherosclerosis. Front Pharmacol. 2019;10:306.
7.
VinchiF, et al. Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction. Eur Heart J. 2020;41(28):2681–95.
8.
BaiT, et al. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic Biol Med. 2020;160:92–102.
9.
KordiN, et al. Ferroptosis and aerobic training in ageing: A review. Clin Hemorheol Microcirc. 2024. Epub ahead of print.
10.
QuinnJJ, ChangHY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62.
11.
GaoF, et al. LncRNA HOXA11-AS promotes vascular endothelial cell injury in atherosclerosis by regulating the miR-515-5p/ROCK1 axis. ESC Heart Fail. 2022;9(4):2259–71.
12.
WeiJ, et al. Long non-coding RNA FGD5 antisense RNA 1 targets Baculovirus inhibitor 5 via microRNA-497-5p to alleviate calcific aortic valve disease. Clin Hemorheol Microcirc. 2024;86(3):285–302.
13.
HurstLD, SmithNG. Molecular evolutionary evidence that H19 mRNA is functional. Trends Genet. 1999;15(4):134–5.
14.
HanDK, et al. H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J Clin Invest. 1996;97(5):1276–85.
15.
BitarafanS, et al. Association of Increased Levels of lncRNA H19 in PBMCs with Risk of Coronary Artery Disease. Cell J. 2019;20(4):564–8.
16.
HuangY, et al. Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5. Front Neurol. 2019;10:32.
17.
XuC, et al. beta-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. Pharmacol Res. 2023;191:106739.
18.
ChenJ, et al. Metformin may induce ferroptosis by inhibiting autophagy via lncRNA H19 in breast cancer. FEBS Open Bio. 2022;12(1):146–53.
DimmelerS, et al. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the `response to injury’ hypothesis. Circulation. 1997;95(7):1760–3.
21.
KontushA, et al. Mildly oxidized LDL particle subspecies are distinct in their capacity to induce apoptosis in endothelial cells: role of lipid hydroperoxides. FASEB J. 2003;17(1):88–90.
22.
XiongG, JiangX, SongT. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease. Rev Assoc Med Bras. 2019;65(2):110–7.
23.
YangY, et al. Knockdown of lncRNA H19 alleviates ox-LDL-induced HCAECs inflammation and injury by mediating miR-20a-5p/HDAC4 axis. Inflamm Res. 2022;71(9):1109–21.
24.
TangD, et al. The molecular machinery of regulated cell death. Cell Res. 2019;29(5):347–64.
25.
HanssonGK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95.
26.
AdayAW, MatsushitaK. Epidemiology of Peripheral Artery Disease and Polyvascular Disease. Circ Res. 2021;128(12):1818–32.
27.
GalluzziL, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486–541.
28.
DixonSJ, StockwellBR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10(1):9–17.
29.
XiangP, et al. Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE(–/–)mice. Theranostics. 2023;13(14):4993–5016.
30.
XiaoFJ, et al. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis. Biochem Biophys Res Commun. 2019;515(3):448–54.
31.
YangWS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317–31.
32.
KoppulaP, ZhuangL, GanB. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620.
33.
WangKC, ChangHY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–14.
34.
WangM, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26(11):2329–43.
35.
MaoC, et al. A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. Cancer Res. 2018;78(13):3484–96.
36.
VoellenkleC, et al. Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep. 2016;6:24141.
37.
HanY, et al. Silencing of H19 inhibits the adipogenesis and inflammation response in ox-LDL-treated Raw264.7 cells by up-regulating miR-130b. Mol Immunol. 2018;93:107–14.
38.
ShiX, et al. Long non-coding RNA H19 in atherosclerosis: what role?Mol Med. 2020;26(1):72.
